Effect of recombinant human growth hormone on liver fat content in young adults with nonalcoholic fatty liver disease.

Chelsea S PanJulian J WeissLindsay T FourmanColleen BucklessKaren L BranchHang LeeMartin TorrianiMadhusmita MisraTakara L Stanley

Published in: Clinical endocrinology (2020)

Data from this pilot study suggest that rhGH treatment in young adults with obesity and NAFLD may have benefits to reduce liver fat content, although larger studies are needed to confirm this effect.

Keyphrases

recombinant human
growth hormone
young adults
adipose tissue
insulin resistance
metabolic syndrome
weight loss
type diabetes
fatty acid
electronic health record
combination therapy
case control
middle aged
body mass index